NovaBridge Biosciences logo

NovaBridge Biosciences

NBP | NASDAQ
Chart Builder DCF Calculator
$0.79
-$0.06 (-7.05%)
At close: Nov 16, 2026, 4:00 PM ET
$0.79
$0.00 (-0.06%)
After-hours: Nov 16, 2026, 7:30 PM ET
-7.05%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 16, 2026
25
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #933/1021 (Top 91%)

Key Statistics

Market Data

Market Cap $91.23M
1D Range
0.77 0.84
52W Range
0.77 4.63

Valuation (TTM)

PE -1.36
PB 0.45
EV/EBITDA 1.72

Valuation (NTM)

Forward PE N/A
Forward PEG -0.00
Price Target $9.00
Loading financial charts...

Profile

NovaBridge Biosciences, a biotechnology firm, primarily focuses on pioneering immuno-oncology treatments for cancer patients within the United States. Its development pipeline features several signifi...

Sector Healthcare
Industry Biotechnology
Employees 30
IPO Date Jan 17, 2020
Fiscal Year January - December

Latest News

No news articles available yet.

Earnings

Next Earnings
Mar 31, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$9.00
Upside
+1039.24%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.